Search Results - "Quiceno, Mary"

Cognitive Training and Transcranial Direct Current Stimulation in Mild Cognitive Impairment: A Randomized Pilot Trial by Das, Namrata, Spence, Jeffrey S, Aslan, Sina, Vanneste, Sven, Mudar, Raksha, Rackley, Audette, Quiceno, Mary, Chapman, Sandra Bond

“…Transcranial direct current stimulation (tDCS), a non-invasive stimulation, represents a potential intervention to enhance cognition across clinical…”
Get full text

Validation of olfactory deficit as a biomarker of Alzheimer disease by Woodward, Matthew R, Amrutkar, Chaitanya V, Shah, Harshit C, Benedict, Ralph H B, Rajakrishnan, Sanjanaa, Doody, Rachelle S, Yan, Li, Szigeti, Kinga

“…We evaluated smell identification as a biomarker for Alzheimer disease (AD) by assessing its utility in differentiating normal aging from an amnestic disorder…”
Get full text

A blood screening test for Alzheimer's disease by O'Bryant, Sid E, Edwards, Melissa, Johnson, Leigh, Hall, James, Villarreal, Alcibiades E, Britton, Gabrielle B, Quiceno, Mary, Cullum, C. Munro, Graff-Radford, Neill R

“…Abstract Introduction This study combined data across four independent cohorts to examine the positive and negative predictive values of an Alzheimer's disease…”
Get full text

Blood-based protein predictors of dementia severity as measured by δ: Replication across biofluids and cohorts by Royall, Donald R., Bishnoi, Ram J., Palmer, Raymond F., Pavlik, Valory, Massman, Paul, Darby, Eveleen, Rodriguear, Monica, Ansari, Aisha Khaleeq, DeToledo, John C., Reddy, Hemachandra, Wilms, Henrick, Johnson, Kim, Perez, Victoria, Fairchild, Thomas, Knebl, Janice, O'Bryant, Sid E., Hall, James R., Johnson, Leigh, Barber, Robert C., Mains, Douglas, Alvarez, Lisa, Cullum, Munro, Rosenberg, Roger, Williams, Benjamin, Quiceno, Mary, Reisch, Joan, Hynan, Linda S., Huebinger, Ryan, Smith, Janet, Nguyen, Trung, Royall, Donald, Palmer, Raymond, Polk, Marsha, Stevens, Alan, Ory, Marcia, Paydarfar, David, Bertelson, John, Woon, Martin, Ayres, Gayle, Aguirre, Alyssa, Wilhelmsen, Kirk C., Tilson, Jeffrey L.

“…Dementia severity can be empirically described by the latent dementia phenotype “δ” and its various composite “homologs”. We have explored δ's blood-based…”
Get full text

Acknowledging Roles and Abilities of Team Members: A Simulated Geriatric Care Team Meeting With the Coopers by Kamm, Kristine, Simpkins, Susan, Shah, Amit, Quiceno, Mary, Gupta, Roopali, Hoggatt Krumwiede, Kim

“…Abstract Introduction Learning to practice interprofessionally requires knowledge of and appreciation for the roles and responsibilities of other health…”
Get full text

Associations of Age and Sex with Levels of Tau PET in Screened Participants from Auτonomy, a Phase 2 Anti‐p‐tau Monoclonal Antibody Trial in Early Symptomatic Alzheimer’s Disease by Kolb, Hartmuth C., Fedgchin, Maggie M, Quiceno, Mary Ellen, Henley, David, Saad, Ziad S.

“…Background The ongoing Auτonomy trial (NCT04619420) enrolls participants presenting with mild cognitive impairment (MCI) or mild AD dementia with a CDR Global…”
Get full text

Associations of Age and Sex with Levels of Tau PET in Screened Participants from Auτonomy, a Phase 2 Anti‐p‐tau Monoclonal Antibody Trial in Early Symptomatic Alzheimer’s Disease by Kolb, Hartmuth C., Fedgchin, Maggie M, Quiceno, Mary Ellen, Henley, David, Saad, Ziad S.

“…Background The ongoing Autonomy trial (NCT04619420) enrolls participants presenting with mild cognitive impairment (MCI) or mild AD dementia with a CDR Global…”
Get full text

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease by Franzmeier, Nicolai, Neitzel, Julia, Rubinski, Anna, Smith, Ruben, Strandberg, Olof, Ossenkoppele, Rik, Hansson, Oskar, Ewers, Michael

“…In Alzheimer’s diseases (AD), tau pathology is strongly associated with cognitive decline. Preclinical evidence suggests that tau spreads across connected…”
Get full text

In‐vivo Braak Stage Distribution of Screened and Randomized Participants from Auτonomy, a Phase 2 Anti‐p‐tau Monoclonal Antibody Trial in Early Symptomatic Alzheimer’s Disease by Saad, Ziad S., Cohen, Julie S, Fedgchin, Maggie M, Quiceno, Mary Ellen, Henley, David, Kolb, Hartmuth C.

“…Background Tau PET is the gold standard for in‐vivo quantification of tau neurofibrillary tangles (NFT) which, along with amyloid plaques and…”
Get full text

In‐vivo Braak Stage Distribution of Screened and Randomized Participants from Auτonomy, a Phase 2 Anti‐p‐tau Monoclonal Antibody Trial in Early Symptomatic Alzheimer’s Disease by Saad, Ziad S., Cohen, Julie S, Fedgchin, Maggie M, Quiceno, Mary Ellen, Henley, David, Kolb, Hartmuth C.

“…Background Tau PET is the gold standard for in‐vivo quantification of tau neurofibrillary tangles (NFT) which, along with amyloid plaques and…”
Get full text

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology by Shen, Xinpeng, Ma, Sisi, Vemuri, Prashanthi, Simon, Gyorgy

“…Causal Structure Discovery (CSD) is the problem of identifying causal relationships from large quantities of data through computational methods. With the…”
Get full text

Type 2 diabetes mellitus, brain atrophy, and cognitive decline by Moran, Chris, Wang, Wei, Callisaya, Michele, Aisen, Paul, Jagust, William, Trojanowki, John Q, Beckett, Laurel, Green, Robert C, Saykin, Andrew J, Montine, Tom, Gamst, Anthony, Gessert, Devon, Kornak, John, Alexander, Gene, DeCarli, Charles, Bandy, Dan, Koeppe, Robert A, Mathis, Chet, Cairns, Nigel J, Taylor-Reinwald, Lisa, Trojanowki, J.Q, Korecka, Magdalena, Neu, Scott, Foroud, Tatiana M, Potkin, Steven, Shen, Li, Frank, Richard, Kaye, Jeffrey, Dolen, Sara, Pawluczyk, Sonia, Spann, Bryan M, Brewer, James, Lord, Joanne L, Chowdhury, Munir, Bell, Karen L, Morris, John C, Leon, Sue, Schneider, Stacy, deToledo-Morrell, Leyla, Shah, Raj C, Albert, Marilyn, Onyike, Chiadi, Kielb, Stephanie, Rusinek, Henry, Doraiswamy, P Murali, Coleman, R Edward, Wolk, David, Jicha, Greg, Oakley, MaryAnn, Simpson, Donna M, Porsteinsson, Anton P, McAdams-Ortiz, Catherine, Womack, Kyle, Martin-Cook, Kristen, Lah, James J, Burns, Jeffrey M, Anderson, Heather S, Silverman, Daniel H.S, Graff-Radford, Neill R, Johnson, Heather, Farlow, Martin R, Hake, Ann Marie, Matthews, Brandy R, Herring, Scott, Carson, Richard E, MacAvoy, Martha G, Hosein, Chris, Caldwell, Curtis, Mudge, Benita, Rogers, John, Kerwin, Diana, Mesulam, Marek-Marsel, Taylor, Joy L, Tinklenberg, Jared, Sabbagh, Marwan, Kowall, Neil, Killiany, Ronald, Bwayo, Salome K, Lerner, Alan, Hudson, Leon, Ogrocki, Paula, Bartha, Dr Rob, Johnson, Sterling, Asthana, Sanjay, Scharre, Douglas W, Zimmerman, Earl A, Brown, Alice D, Pearlson, Godfrey D, Blank, Karen, Santulli, Robert B, Williamson, Jeff D, Ott, Brian R, Correia, Stephen, Rachinsky, Irina, Drost, Dick, Hernando, Raymundo, Sarrael, Antero, Shim, Hyungsub, Chaing, Gloria, Smith, Amanda

“…OBJECTIVETo study longitudinal relationships between type 2 diabetes mellitus (T2DM), cortical thickness, and cognitive function in older people with normal…”
Get full text

A phase 3 trial of IV immunoglobulin for Alzheimer disease by Relkin, Norman R, Thomas, Ronald G, Rissman, Robert A, Brewer, James B, Rafii, Michael S, van Dyck, Christopher H, Jack, Clifford R, Sano, Mary, Knopman, David S, Raman, Rema, Szabo, Paul, Gelmont, David M, Fritsch, Sandor, Aisen, Paul S

“…We tested biweekly infusions of IV immunoglobulin (IVIg) as a possible treatment for mild to moderate Alzheimer disease (AD) dementia. In a phase 3,…”
Get full text

Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states by Mahjoub, Ines, Mahjoub, Mohamed Ali, Rekik, Islem

“…Accurate diagnosis of mild cognitive impairment (MCI) before conversion to Alzheimer’s disease (AD) is invaluable for patient treatment. Many works showed that…”
Get full text

Remote Neuropsychological Assessment in Rural American Indians with and without Cognitive Impairment by Wadsworth, Hannah E, Galusha-Glasscock, Jeanine M, Womack, Kyle B, Quiceno, Mary, Weiner, Myron F, Hynan, Linda S, Shore, Jay, Cullum, C Munro

“…To determine the feasibility and reliability of a brief battery of standard neuropsychological tests administered via video teleconference (VTC) to a sample of…”
Get full text

KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease by Neitzel, Julia, Franzmeier, Nicolai, Rubinski, Anna, Dichgans, Martin, Brendel, Matthias, Malik, Rainer, Ewers, Michael

“…Klotho-VS heterozygosity (KL-VS het ) is associated with reduced risk of Alzheimer’s disease (AD). However, whether KL-VS het is associated with lower levels…”
Get full text

Tau‐Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease by McCollum, Lauren, Jack, Clifford R., Thomas, Ronald G., Walter, Sarah, Sather, Tamie, Donohue, Michael, Bernstein, Matthew, Borowski, Bret, Kantarci, Kejal, Ward, Chad, Koeppe, Robert A., Mathis, Chet, Cairns, Nigel J., Korecka, Magdalena, Figurski, Michal, Crawford, Karen, Snyder, Peter J., Molchan, Susan, Lind, Betty, Dolen, Sara, Spann, Bryan M., Vanderswag, Helen, Fleisher, Adam, Rountree, Susan, Dang, Mimi, Honig, Lawrence S., Leon, Sue, Mintun, Mark A., Schneider, Stacy, Clark, David, Brockington, John, Roberson, Erik, Albert, Marilyn, Kielb, Stephanie, Michel, Christina A., Leon, Mony J, De Santi, Susan, Wolk, David, Smith, Charles D., Jicha, Greg, Oates, Elizabeth, Conrad, Gary, Lopez, Oscar L., Oakley, MaryAnn, Goldstein, Bonnie S., Martin, Kim, Makino, Kelly M., Mulnard, Ruth A., Ortiz, Catherine Mc Adams, Womack, Kyle, Quiceno, Mary, Arrastia, Ramon Diaz, Weiner, Myron, DeVous, Michael, Cellar, Janet S., Bums, Jeffrey M., Anderson, Heather S., Woo, Ellen, Parfitt, Francine, Kendall, Tracy, Johnson, Heather, Hake, Ann Marie, Hunt, Cynthia, Carson, Richard E., MacAvoy, Martha G., Bergman, Howard, Stefanovic, Bojana, Feldman, Howard, Assaly, Michele, Kertesz, Andrew, Rogers, John, Trost, Dick, Wu, Chuang Kuo, Johnson, Keith A., Marshall, Gad, Taylor, Joy L., Lane, Barton, Rosen, Allison, Belden, Christine M., Kowall, Neil, Norbash, Alexan, Hudson, Leon, Olichney, John, Lee, T Y, Bartha, Rob, Johnson, Sterling, Asthana, Sanjay, Capote, Horacio, Williamson, Jeff D., Watkins, Franklin, Salloway, Stephen, Malloy, Paul, Rosen, Howard J., Miller, Bruce L., Mintzer, Jacobo, Bachman, David, Finger, Elizabether, Rogers, John, Kertesz, Andrew, Fargher, Kristin

“…Objective Tau neurofibrillary tangles (T) are the primary driver of downstream neurodegeneration (N) and subsequent cognitive impairment in Alzheimer's disease…”
Get full text

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics by Varatharajah, Yogatheesan, Ramanan, Vijay K., Iyer, Ravishankar, Vemuri, Prashanthi

“…In the Alzheimer’s disease (AD) continuum, the prodromal state of mild cognitive impairment (MCI) precedes AD dementia and identifying MCI individuals at risk…”
Get full text

Instrumented Gait and Balance Analyses in Progressive Supranuclear Palsy and Mild Cognitive Impairment compared with Parkinson Disease (P4.013) by Nguyen, Trung, Brown, L. Steven, Logan, Rebecca, O’Suilleabhain, Padraig, Dewey, Richard, Quiceno, Mary, Khemani, Pravin

“…Abstract only…”
Get full text

Vascular burden and Alzheimer disease pathologic progression by Lo, Raymond Y., Jagust, William J., Weiner, Michael, Petersen, Ronald, Jack, Clifford R., Trojanowki, John Q., Toga, Arthur W., Green, Robert C., Donohue, Michael, Sather, Tamie, Harvey, Danielle, Dale, Anders, Bernstein, Matthew, Felmlee, Joel, Fox, Nick, Thompson, Paul, Koeppe, Robert A., Chen, Kewei, Cairns, Nigel J., Shaw, Les, Foroud, Tatiana M., Potkin, Steven, Kachaturian, Zaven, Snyder, Peter J., Quinn, Joseph, Lind, Betty, Schneider, Lon S., Vanderswag, Helen, Johnson, Kris, Doody, Rachelle S., Bell, Karen L., Ances, Beau, Carroll, Maria, Mintun, Mark A., Schneider, Stacy, Griffith, Randall, Mitsis, Effie, Romirowsky, Aliza, Varon, Daniel, Roberts, Peggy, De Santi, Susan, Doraiswamy, P. Murali, Arnold, Steven E., Karlawish, Jason H., Smith, Charles D., Porsteinsson, Anton P., Martin, Kim, Ismail, M. Saleem, Brand, Connie, Mathews, Dana, Quiceno, Mary, Weiner, Myron, DeVous, Michael, Levey, Allan I., Lah, James J., Burns, Jeffrey M., Swerdlow, Russell H., Bartzokis, George, Silverman, Daniel H.S., Graff-Radford, Neill R, Johnson, Heather, Caldwell, Curtis, Assaly, Michele, Kertesz, Andrew, Bernick, Charles, Mesulam, Marek-Marsel, Lipowski, Kristina, Wu, Chuang-Kuo, Turner, Raymond Scott, Johnson, Kathleen, Reynolds, Brigid, Lane, Barton, Jacobson, Sandra, Budson, Andrew E., Johnson, Patricia Lynn, Obisesan, Thomas O., Wolday, Saba, Bwayo, Salome K., Lerner, Alan, Fletcher, Evan, Carmichael, Owen, Kittur, Smita, Bartha, Dr Rob, Preda, Adrian, Tariot, Pierre, Fleisher, Adam, Reeder, Stephanie, Capote, Horacio, Kataki, Maria, Celmins, Dzintra, Pearlson, Godfrey D., Anderson, Karen, Santulli, Robert B., Sink, Kaycee M., Garg, Pradeep, Ott, Brian R., Malloy, Paul, Mintzer, Jacobo, Spicer, Kenneth, Finger, Elizabether

“…OBJECTIVE:To investigate the vascular contribution to longitudinal changes in Alzheimer disease (AD) biomarkers. METHODS:The Alzheimerʼs Disease Neuroimaging…”
Get full text